Investing
The California Supreme Court on Wednesday agreed to hear the appeal of a state appeals court decision that let most of a state law...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
Investing
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s highlights of the most timely ETF news emailed to you weekly....
Investing
In these times of deep divisions, one thing Americans can agree on is the Super Bowl. It has become our secular version of Carnival...
Investing
A glimmer of hope appeared Friday for beleaguered New York Community Bancorp after its stock rose 17% on strong trading volume. Investors seemed reassured...
Investing
As I mentioned on my last Blog Post, blood clot drug Eliquis, sold by both Bristol Myers Squibb BMY and Pfizer (PFE), is likely...
Investing
Cathie Wood’s ARK Investment Management and crypto asset manager 21Shares amended their application for a spot bitcoin exchange traded fund to include a surveillance...
Investing
Micron Technology Inc. shares rose in the extended session Wednesday after the memory-chip maker’s chief executive called the bottom on the sector, and quarterly...
Investing
The Wagner Group’s attempted coup over weekend in Russia cast some doubt over Russian President Vladimir Putin’s political power, and raised uncertainty surrounding the...
Investing
Oil futures ended lower on Tuesday after delivering only a modest rise the previous session following a chaotic weekend in Russia that saw the...
Investing
Gold edged lower Tuesday as Treasury yields rose and investors continued to fret over whether stubborn inflation around the world will push central banks...
Investing
By Michael Susin Pensana said late Tuesday that it has secured a further financing for the development of the Longonjo mine in Angola. The...
Investing
By Stephen Nakrosis HashiCorp said it acquired BluBracket, a Palo Alto, California-based startup which “helps companies ship secure code without compromising development speed or...
Investing
By Chris Wack Edgewise Therapeutics shares were up 10% at $7.56 after the company said it saw positive 12-month topline results from its ongoing...
